Sign outside of hospital with text indicating admitting and discharge of patients
·
2 MIN READ

Give hospital-based doctors access to outpatient formulary info

Without it, cost can lead to medication nonadherence and readmissions. Learn more about new AMA policy to get real-time information to physicians.

Public Health
Hand scanning a prescription bottle
·
3 MIN READ

How a $10 copay could mean life or death for some patients

Learn with the AMA how payers’ focus on shifting costs to patients can clash with medicine’s mission of bettering public health.

Patient Support & Advocacy
Washington D.C., Capitol Hill, Capitol Building, cherry blossoms
·
7 MIN READ

Meet the AMA’s Capitol Hill allies protecting patients and practices

Learn how a diverse group of lawmakers has worked with the AMA to carry favorable legislation over the finish line and block harmful measures.

Federal Advocacy
·
4 MIN READ

Jan. 22, 2021: Judicial Advocacy Update

U.S. Supreme Court: State law can require PBMs to pay fair amount and more in the latest Judicial Advocacy Update.

Advocacy Update
Pharmacy
·
4 MIN READ

U.S. Supreme Court: State law can require PBMs to pay fair amount

Physicians asked high court to uphold a state PBM drug-pricing law protecting access to independent and rural pharmacies, and the justices agreed.

Public Health
·
2 MIN READ

Jan. 8, 2021: Judicial Advocacy Update

Courts block Jan. 1 implementation of most favored nations drug pricing model in the latest judicial Advocacy Update.

Advocacy Update
·
9 MIN READ

Dec. 4, 2020: National Advocacy Update 

Administration finalizes drug pricing actions and more in the latest National Advocacy Update.

Advocacy Update
·
4 MIN READ

Top news stories from AMA Morning Rounds®: Week of Oct. 26, 2020

In the news: COVID-19 cases in the U.S., USPSTF draft recommendation for colorectal cancer screening, requirement for insurers to disclose prices.

Publications & Newsletters
·
12 MIN READ

Oct. 9, 2020: National Advocacy Update

Register for AMA webinar next week: CDC update on COVID-19 vaccine development and distribution and more in the latest National Advocacy Update.

Advocacy Update